z-logo
open-access-imgOpen Access
Interferon Free Therapy with and Without Ribavirin for Genotype 1 HCV Cirrhotic Patients in the Real World Experience
Author(s) -
Dorota ZarębskaMichaluk,
Jerzy Jaroszewicz,
Ewa Janczewska,
Hanna Berak,
Andrzej Horban,
Marek Sitko,
Aleksander Garlicki,
Beata Dobracka,
Agnieszka CzaużAndrzejuk,
Dorota Dybowska,
Waldemar Halota,
Małgorzata Pawlowska,
Magdalena TudrujekZdunek,
Krzysztof Tomasiewicz,
Włodzimierz Mazur,
Zbigniew Deroń,
Teresa BelicaWdowik,
Barbara BakaĆwierz,
Iwona Buczyńska,
Krzysztof Simon,
Anna Piekarska,
Jolanta Białkowska,
Beata Lorenc,
Rafał Krygier,
A. Staniaszek,
Jakub Klapaczyński,
Jolanta Citko,
Łukasz Socha,
Marta WawrzynowiczSyczewska,
Łukasz Laurans,
Robert Flisiak
Publication year - 2018
Publication title -
hepatitis monthly
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.264
H-Index - 37
eISSN - 1735-3408
pISSN - 1735-143X
DOI - 10.5812/hepatmon.80761
Subject(s) - medicine , ribavirin , discontinuation , adverse effect , regimen , cirrhosis , cohort , gastroenterology , hepatology , alpha interferon , pegylated interferon , hepatitis c , surgery , hepatitis c virus , interferon , immunology , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom